11.07.2015 Views

Care and Maintenance to Reduce Vascular Access Complications

Care and Maintenance to Reduce Vascular Access Complications

Care and Maintenance to Reduce Vascular Access Complications

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Care</strong> <strong>and</strong> <strong>Maintenance</strong> <strong>to</strong> <strong>Reduce</strong> <strong>Vascular</strong> <strong>Access</strong> <strong>Complications</strong>The Four Elements of Flushing <strong>and</strong> LockingFlushing <strong>and</strong> locking interventions involve four elements that need <strong>to</strong> be described in client specific orders<strong>and</strong>/or in established medical directives. It is important that flushing/locking interventions are based onst<strong>and</strong>ards of practice, evidence-based practice guidelines <strong>and</strong> current research (EPIC, 2001b; INS, 2000; RCN 2003).These four elements include:■■■■Type of solution;Concentration of solution;Volume of solution; <strong>and</strong>Frequency of administration.1. Type of solutionFlushing: The nurse should choose normal saline or other compatible solutions <strong>to</strong> flush the VAD in order<strong>to</strong> prevent incompatibilities between two infusates.Locking: Locking solutions used with positive pressure technique maintain catheter patency by preventingblood reflux <strong>and</strong> by reducing the risk of blood clotting in the device lumen when blood reflux occurs.Locking solutions include:■■Normal saline; <strong>and</strong>Heparin.Positive Pressure Saline LockingThere is a significant amount of literature which supports normal saline locking <strong>to</strong> maintainpatency of CVADs when using valved CVADs (e.g. PASV ® or Groshong ® ) <strong>and</strong>/or when using positivepressure caps (EPIC, 2001b; INS, 2000; RCN 2003).Positive Pressure Heparin LockingWhen open-ended devices are used without positive pressure technology (i.e., positive pressurecaps), blood can reflux in<strong>to</strong> the device lumen. To reduce the incidence of the refluxed blood clottingheparin can be used <strong>to</strong> lock the device. Concentrations of heparin reported for use in CVADs rangefrom 10-1000 IU/mL of which the most commonly reported heparin concentration is 100 IU/mL.A meta-analysis of r<strong>and</strong>omized controlled trials focusing on CVADs (CDC, 2002) concluded thatheparin significantly reduced bacterial colonization <strong>and</strong> showed a strong but non-significant trend<strong>to</strong>wards reductions of catheter-related bacteremia. Because thrombi <strong>and</strong> fibrin deposits on cathetersmight serve as a nidus for microbial colonization of intravascular catheters the use of anticoagulantsmight have a role <strong>to</strong> play in the prevention of catheter related blood stream infections (CRBSI) (CDC,2002). Despite this benefit, heparin should be used with caution because it poses the risk of seriouscomplications even in small doses. Heparin has been associated with iatrogenic hemorrhage (a lifethreateningreaction <strong>to</strong> heparin), heparin induced thrombocy<strong>to</strong>penia (HIT), drug interactions <strong>and</strong>inaccurate blood results (Dougherty, 1997; EPIC 2001b; Hadaway, 2001). Therefore, it should be used onlywhen necessary in order <strong>to</strong> reduce heparin-related complications.30

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!